Milad Darou Company’s potassium iodide tablet is a protective drug used in cases of nuclear radiation release.
This drug should only be used in situations where the country’s official authorities declare that there is a risk of nuclear radiation release.
In this situation, a lot of radioactivity may be released into the air, and potassium iodide tablets help protect the thyroid gland from absorbing radioactive iodine.
After radiation accidents, iodine-131, as the most abundant radioisotope released into the air, can accumulate in the thyroid gland and lead to thyroid and esophageal cancer.
Potassium iodide tablets with a molecular weight of iodine-127 replace iodine-131 in the thyroid and prevent its absorption.
The recommended dosage of this tablet is one tablet per day for people over 12 years of age, and half a tablet for people under 12 years of age.
The dosage of the medicine is as follows:
| Adults (over 18 years old) | Two tablets (130 mg) per day |
| People 12 to 18 years old or weighing at least 70 kg | Two tablets (130 mg) per day |
| People 12 to 18 years old or weighing less than 70 kg | One tablet (65 mg) per day |
| Children 3 to 12 years old | One tablet per day (65 mg) |
| Children 1 month to 3 years | 32.5 mg per day |
| Infants up to one month old | 16.25 mg per day |
Children 1 month to 3 years old should take four teaspoons of the prepared solution.
Infants up to one month old should take four teaspoons of the prepared solution.
Potassium iodide tablets can be taken in two forms: crushed tablets or mixed with a large volume of liquid. If mixed with liquid, care should be taken to ensure that the entire dose is taken correctly.
When this medicine is prescribed, a dose should be taken every 24 hours, which is determined based on the age and weight of the person taking it.
Care should be taken not to take more than the prescribed amount.